The Cochrane Heart Group is funded by the NIHR Cochrane Infrastructure funding.
NIHR Cochrane Programme Grants
We are currently collaborating with NHS Blood and Transplant (Lise Estcourt) under a NIHR Cochrane Programme Grant for alternatives and adjuncts to transfusion to prevent and treat bleeding in people who are at risk of serious life-threatening bleeding (since April 2018). The outcome will be one systematic review with network meta-analysis entitled Interventions to prevent and treat bleeding in cardiac surgery.
We have also had two NIHR Cochrane Programme grants in the past:
2011 - 2013 University of Warwick (Karen Rees) for a set of reviews and updates on lifestyle and pharmacological interventions for the primary prevention of cardiovascular disease.
2007- 2010 University of Exeter (Rod Taylor) for a set of reviews and updates on public health and prevention for cardiovascular diseases.
NIHR Cochrane Incentive funding
We also have a successful record of receiving NIHR Cochrane Incentive funding:
New review (in progress, due by 31 January 2020): Transcatheter versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk
New review (in progress, due by 31 December 2019): Non-vitamin K antagonist oral anticoagulants (NOACs) for percutaneous coronary intervention (PCI): a network meta-analysis
New review (published in February 2018): Exercise-based cardiac rehabilitation for patients with stable angina
Updated review (in progress): 'Mediterranean' dietary pattern for the prevention and treatment of cardiovascular disease
Updated review (published June 2017): Home-based versus centre-based cardiac rehabilitation
New review (published in June 2018): Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
Cochrane Review Support Programme
2017 New review (published June 2018): Mobile phone based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease
2016 New review (published August 2017): Drug-eluting stents versus bare metal stents for patients with acute coronary syndrome
2015 Updated review (published March 2017): Fixed-dose combination therapy for the prevention of cardiovascular disease